AMRX
AmnealANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
AMRX vs peer average
95/100
AMRX vs. peer average (A vs. D)
Grade spread
C 2 · D 8
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Large-cap biopharma benchmark with substantially greater scale; limited operating comparability to Amneal’s generics, specialty, and biosimilar mix.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AMRX
Amneal
AMGN
Amgen
Grade
A
D
Momentum
83
37
Value
64
63
Sentiment
47
34
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AMGN
AMRX / AMGN
Grade Position
Above peers
AMRX vs. peer average (A vs. D)
95/100
Momentum
83
AMRXValue
64
AMRXSentiment
47
AMRXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AMRX
AMGN is the first peer returned for this comparison set.

